SPAC140.04 Antibody

What is the target of SPAC140.04 Antibody and what cellular processes is it involved in?

SPAC140.04 Antibody targets a specific protein that may be structurally or functionally related to the SP140 protein family. SP140 is a nuclear body protein expressed primarily in leukocytes and plays roles in immune response regulation. The protein is involved in transcriptional regulation through chromatin interactions and has been implicated in immune system development. When using this antibody, it's essential to first validate its specificity against your particular target using multiple methodological approaches including Western blotting, immunoprecipitation, and immunofluorescence to confirm binding to the correct target .

What are the recommended experimental applications for SPAC140.04 Antibody?

Based on related antibody research, SPAC140.04 Antibody would likely be applicable for several standard immunological techniques including:

• Western blotting (WB)

• Immunohistochemistry (IHC)

• Immunocytochemistry/Immunofluorescence (ICC-IF)

• Flow cytometry

• Immunoprecipitation (IP)

Each application requires specific optimization of antibody concentration, incubation conditions, and detection methods. For flow cytometry applications, typically begin with a 1:20 dilution in PBS containing 0.1% FBS as a starting point, similar to protocols used for other research antibodies .

What is the recommended storage condition for maintaining SPAC140.04 Antibody activity?

For optimal activity preservation:

• Store at 2-8°C for short-term usage (up to 1 month)

• For long-term storage, aliquot and keep at -20°C to -80°C

• Avoid repeated freeze-thaw cycles (no more than 3) as this can significantly reduce antibody activity

• Protect from light, especially if the antibody is conjugated with a fluorophore

• Do not freeze if the antibody is conjugated with enzymes like HRP or APC

How should I determine the optimal working concentration of SPAC140.04 Antibody for my specific experimental system?

A systematic titration approach is essential:

Begin with manufacturer's recommended dilution, then perform a systematic titration using a sample known to express your target protein. For each application, include appropriate positive and negative controls. Plot signal-to-noise ratio against antibody concentration to determine optimal working concentration that maximizes specific signal while minimizing background .

What controls should I include when using SPAC140.04 Antibody to ensure experimental validity?

A robust experimental design must include:

• Positive control: Sample known to express the target protein

• Negative control: Sample known not to express the target protein

• Technical controls:

  • Isotype control: Matched isotype antibody from same species

  • Secondary antibody only: To assess non-specific binding

  • Blocking peptide control: Pre-incubation with the immunizing peptide

  • Knockout/knockdown validation: Using genetic models lacking the target

These controls allow for accurate interpretation of results and differentiation between specific and non-specific signals, particularly in complex tissue samples or when investigating proteins with potential cross-reactivity issues .

How can I validate SPAC140.04 Antibody specificity for my particular experimental system?

Validation requires a multi-method approach:

• Western blot analysis: Confirm single band of expected molecular weight

• Immunoprecipitation followed by mass spectrometry: Identify pulled-down proteins

• Orthogonal target detection: Compare with alternative antibodies or detection methods

• Genetic models: Test in knockout/knockdown systems

• Peptide competition: Pre-absorb antibody with immunizing peptide

Document all validation steps systematically with appropriate positive and negative controls. For publication-quality data, validation in at least two independent methods is recommended, with emphasis on demonstrating specificity in the particular cell/tissue type being studied .

What methodologies can address potential cross-reactivity of SPAC140.04 Antibody with related protein family members?

Cross-reactivity assessment is critical, especially for protein families with high homology:

• Bioinformatic analysis: Compare epitope sequence across related proteins

• Recombinant protein panel testing: Test antibody against purified related proteins

• Cell line panel: Use cells expressing different family members

• Knockout/knockdown validation: Confirm signal loss in absence of specific target

• Peptide competition: Test with peptides from related proteins

Results from these tests should be presented in a comprehensive table showing percent cross-reactivity with each related protein. For applications requiring absolute specificity, absorption steps may be necessary to remove cross-reactive antibodies from your working solution .

What are the most common causes of high background when using SPAC140.04 Antibody, and how can they be addressed?

High background can severely impact experimental interpretation. Systematic troubleshooting includes:

Document all optimization steps and include representative images of both problematic and optimized conditions when publishing results or presenting data .

How can I optimize SPAC140.04 Antibody for flow cytometry applications in primary immune cells?

Optimization for flow cytometry requires special consideration:

• Sample preparation:

  • Use fresh samples when possible

  • Optimize fixation (PFA concentration and time)

  • Test permeabilization reagents if targeting intracellular epitopes

• Staining protocol:

  • Titrate antibody concentration (typically starting at 1:20 dilution)

  • Optimize incubation temperature and time

  • Include FcR blocking to reduce non-specific binding

• Analysis considerations:

  • Set proper compensation when using multiple fluorophores

  • Use fluorescence-minus-one (FMO) controls

  • Apply consistent gating strategy across samples

For immune cells specifically, consider additional blocking steps with normal serum matched to the host species of your secondary antibody. Document flow cytometry methodology according to MIFlowCyt standards for publication .

What quantitative approaches should be used to analyze and interpret SPAC140.04 Antibody staining patterns in tissue samples?

Rigorous quantitative analysis is essential for reproducible research:

• Image acquisition:

  • Use consistent exposure settings across all samples

  • Capture multiple fields per sample (minimum 5-10)

  • Include scale bars and magnification information

• Quantification methods:

  • Measure staining intensity using integrated density values

  • Quantify percent positive cells in appropriate regions of interest

  • Apply threshold consistently across all samples

• Statistical analysis:

  • Use appropriate statistical tests based on data distribution

  • Include biological replicates (n ≥ 3)

  • Report both effect size and p-values

For publications, provide representative images alongside quantification with clearly defined methods for threshold determination and region of interest selection .

How can I reconcile contradictory results between SPAC140.04 Antibody staining and other detection methods for the same target?

Contradictory results require systematic investigation:

• Technical assessment:

  • Verify antibody lot consistency

  • Check for protocol differences between methods

  • Evaluate epitope accessibility in different preparation methods

• Biological considerations:

  • Different isoforms may be detected by different methods

  • Post-translational modifications may affect epitope recognition

  • Expression levels may be below detection threshold in some methods

• Reconciliation approaches:

  • Use orthogonal methods for validation

  • Perform knockout/knockdown controls in each system

  • Consider epitope mapping to understand binding determinants

Present contradictory data transparently in publications, alongside potential explanations and additional validation experiments that help resolve the discrepancies .

How can SPAC140.04 Antibody be applied in studying immune-related pathologies?

For immune-related disease research:

• Tissue expression analysis:

  • Compare target protein levels between healthy and diseased tissues

  • Correlate expression with disease severity or progression

  • Identify cell-specific expression patterns in complex tissues

• Functional studies:

  • Use for detecting protein-protein interactions via co-immunoprecipitation

  • Monitor changes in subcellular localization during disease processes

  • Assess post-translational modifications specific to disease states

• Therapeutic monitoring:

  • Evaluate target modulation after experimental treatment

  • Develop biomarker applications for disease monitoring

  • Use in antibody-dependent cellular cytotoxicity (ADCC) assays

These approaches should be documented with appropriate controls and statistical analysis across multiple biological replicates to ensure reproducibility and biological significance of findings .

What methodological considerations are important when using SPAC140.04 Antibody in animal models of disease?

Animal model applications require specific optimization:

• Species cross-reactivity:

  • Verify epitope conservation across species

  • Validate antibody in the specific animal model tissue

  • Consider using species-specific secondary antibodies

• Background considerations:

  • Include age-matched controls

  • Account for tissue autofluorescence

  • Use proper blocking of endogenous immunoglobulins

• Quantification approaches:

  • Establish baseline expression in healthy animals

  • Develop consistent scoring systems for pathological changes

  • Use blinded assessment to prevent bias

Document all methodological details, including animal age, sex, strain, and treatment protocols, along with ethical approval information when publishing results .